共 531 条
[51]
Fiege V(2008)Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis Clin Exp Rheumatol 26 S57-726
[52]
Butikofer L(2009)High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition Rheumatology (Oxford) 48 258-1122
[53]
Hellmich B(2014)Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis Autoimmun Rev 13 788-582
[54]
Agueda A(2018)Effect of aspirin on cardiovascular events and bleeding in the healthy elderly N Engl J Med 379 1509-1088
[55]
Monti S(2018)Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study) Ann Rheum Dis 77 348-2026
[56]
Buttgereit F(2017)A Randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of takayasu arteritis Arthritis Rheum 69 846-1798
[57]
de Boysson H(2018)Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: single centre experience from a large tertiary care teaching hospital in Southern India Semin Arthritis Rheum 47 718-375
[58]
Brouwer E(2017)Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients Circulation 136 1114-778
[59]
Cassie R(1994)Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate Arthritis Rheum 37 578-1149
[60]
Mackie SL(2016)The efficacy of mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis Sci Rep 6 38687-228